Avinger Inc. recently announced the closing of its previously announced public offering of 9,857,800 shares of Avinger’s common stock at a price to the public of $3.50 per share.

Obstructive sleep apnea is a common cause of high blood pressure. In the Aug. 17, 2016, issue of the journal Science Signaling, researchers based primarily at the University of Chicago describe the signaling cascade that leads to this form of hypertension and suggest ways to disrupt those signals and prevent elevated blood pressures.

The Detroit Medical Center (DMC) Heart Hospital recently completed a Complex Percutaneous Intervention education course, utilizing an unprecedented four live, clinically complex cases.

Endologix Inc. announced the first two patients with abdominal aortic aneurysms (AAA) have been treated with the Ovation Alto Abdominal Stent Graft System. The patients were treated by Andrew Holden, M.D., and Andrew Hill, M.D., of Auckland City Hospital, Auckland, New Zealand.

The detonation of atomic bombs over the Japanese cities of Hiroshima and Nagasaki in August 1945 resulted in horrific casualties and devastation. The long-term effects of radiation exposure also increased cancer rates in the survivors. But public perception of the rates of cancer and birth defects among survivors and their children is in fact greatly exaggerated when compared to the reality revealed by comprehensive follow-up studies. The reasons for this mismatch and its implications are discussed in a Perspectives review of the Hiroshima/Nagasaki survivor studies published in the August issue of the journal Genetics, a publication of the Genetics Society of America.

Researchers at the Peter Munk Cardiac Centre, Toronto, and at Mayo Clinic are leading the Tailored Antiplatelet Therapy to Lessen Outcomes after Percutaneous Coronary Intervention (TAILOR-PCI) study. This study has received $7 million in additional funding from the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH).

The Medtronic's TurboHawk atherectomy system. Covidien, Medtronic, TurboHawk, Atherectomy system
CSI, cardiovascular systems inc, Diamondback 360, atherectomy device
The Avinger Pantheris atherectomy device, which incorporates OCT intravascular imaging.

Due to poor outcomes from percutaneous transluminal angioplasty (PTA) ballooning of vessels alone, or of stenting in peripheral vessels, atherectomy has been adopted as a new therapy to improve treatment of peripheral artery disease (PAD) and critical limb ischemia (CLI).
Sapien III, Sapien 3, PARTNER III, FDA approval, expanded indication, intermediate risk patients

August 18, 2016 — The U.S. Food and Drug Administration (FDA) has expanded the indications for both the Edwards Lifesciences’ Sapien 3 and Sapien XT transcatheter heart valves for the treatment of patients suffering from severe, symptomatic aortic stenosis who have been determined by a heart team to be at intermediate risk for open-heart surgery. The Sapien valve is the first transcatheter aortic valve replacement (TAVR) therapy to obtain this indication in the United States.

The U.S. healthcare industry has failed to create and sustain an efficient network for storing and sharing patient medical data, but a new proposed strategy could make the process easier and more affordable.

Media Kit Request

Thank you for your interest in Diagnostic and Interventional Cardiology (DAIC) media opportunities.

DAIC provides "buying team" decision-makers in cardiology, interventional cardiology, cardiovascular imaging and cardiac catheterization departments with vital information required to make informed purchasing decisions.  

DAIC provides a wide variety of web, digital, video, educational and custom media products, and integrated media programs, to help advertisers successfully connect with its engaged audience, and to maximize the return on their investment.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now